Gossypol arrests human benign prostatic hyperplastic cell growth at G0/G1 phase of the cell cycle

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1003-1009

  Shidaifat, Falah ^a   Canatan, Halit ^a   Kulp, Samuel K ^a   Sugimoto, Yasuro ^a   Zhang, Yuan ^a   Brueggemeier, Robert W ^a,b   Somers, William J ^b   Chang, William Y ^a   Wang, Hwa Chain ^b   Lin, Young C ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Benign prostatic hyperplasia; Cell cycle; Gossypol; TGF

Indexed keywords

CONTRACEPTIVE AGENT; GOSSYPOL; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY;

CELL DIVISION; G0 PHASE; G1 PHASE; GOSSYPOL; HUMANS; MALE; PROSTATIC HYPERPLASIA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030895983     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Coffey DS and Walsh PC: Clinical and experimental studies of benign prostatic hyperplasia. Urologic Clinics of North America 17: 461-475, 1990.
2. Schroder FZ: 5α-reductase inhibitors and prostatic disease. Clinical Endocrinol 41: 139-147, 1994.
3. Moh PP, Chang CJG, Brueggemeier RW and Lin YC: Effect of gossypol on 5α-reductase and 3α-hydroxysteroiddehydrogenase activities in adult rat testes. Res Comm Chem Pathol Pharmacol 82: 12-26, 1993.
4. Moh PP, Chang CJG, Hu YF, Brueggemeier RW and Lin YC: Effect of gossypol on 5a reductase activity in canine benign prostatic hyperplasia. FASEB J 7: A237, 1992.
5. Kalla NR, Rovan E, Ranga A and Frick J: Effect of gossypol on immature male rats. Acta Eur Fertil 16: 437-446, 1985.
6. Ranga A, Kalla NR and Kanwar U: Effect of gossypol on the fertility of male rats. Acta Eur Fertil 21: 7-12, 1990.
7. Lin YC Chang CJG Moh PP and Brueggcmeier RW: Inhibitory action of gossypol on rat prostate. FASEB J 6: A2031, 1992.
8. Chang WY, Shidaifat F, Chang CJG, Kulp SK, Sugimoto Y, Canatan H, Brueggemeier, RW, and Lin YC: Experimentally-induced prostatic hyperplasia in young beagles: A model to evaluate the chemotherapeutic effects of gossypol. Res Commun Molec Pathol Pharmacol, in press, 1996.
9. Wong YC and Tam CC: Structural changes of the guinea pig prostatic epithelial cells after gossypol treatment. Acta Anat 134: 18-25, 1989.
10. Chang CJG, Ghosh PK, Hu YF, Brueggemeier RW and Lin YC: Antiproliferative and antimetastatic effect of gossypol on Dunning prostate cell-bearing Copenhagen rats, Res Commun Chem Pathol Pharmacol 76: 293-312, 1993.
11. Shidaifat F, Canatan H, Kulp SK, Sugimoto Y, Chang YC, Zhang Y, Brueggemeier RW, Somers WJ and Lin YC: Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-β. Cancer Lett, in press, 1996.
12. Hu Y-F, Chang CJG, Brueggemeier RW and Lin YC: Gossypol inhibits basal and cstrogen stimulated DNA synthesis in humanbreast carcinoma cells. Life Sci 53: 433-438, 1993.
13. Hu Y-F, Chang CJG, Brueggemeier RW and Lin YC: Presence of antitumor activities in the milk collected from gossypol-treated dairy cows. Cancer Lett 87: 17-23, 1994.
14. 31P nuclear magnetic resonance and toxicity Studies. Cancer Res 50: 6936-6943, 1990.
15. Tuszynski GP and Cossu G: Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma and other tissue culture cell lines. Cancer Res 44: 768-771, 1984.
16. Thomas M, Von Hagen V, Moustafa Y, Montmasson M-P and Monet JD: Effects of gossypol on the cell cycle phases in T47-D human breast cancer cells. Anticancer Res 11: 1469-1476, 1991.
17. Wang Y and Rao PN: Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells in vitro. Cancer Res 44: 35-38, 1984.
18. Wu Y-W, Chik CL and Knazek RA: An in vitro and in vivo study of antitumor effects of gossypul on human SW-13 adrenocortical carcinoma. Cancer Res 49: 3754-3758, 1989.
19. Coyle T, Levante S, Shetler M and Winfield J: In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines. J Neuro-oncology 19: 25-35, 1994.
20. Tso WW: Gossypol inhibits Ehrlich ascites tumor cell proliferation. Cancer lett 24: 257-261, 1984.
21. Flack MR. Pyle RG, Mullen NM, Lorenzo B, Wu YW, Knazek RA, Nisula BC and Reidenberg MM: Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metabol 76: 1019-1024, 1993.
22. Glynne-Jones E, Harper ME, Goddard L, Eaton CL, Matthews PN and Griffiths K: Transforming growth factor beta 1 expression in benign and malignant prostate tumors. Prostate 25: 210-218, 1994.
23. Sutkowski DM, Fong C-J, Sensibar JA, Rademaker AW, Sherwood ER, Kozlowski JM and Lee C: Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in culture. Prostate 21: 133-143, 1992.
24. Alexandrow MG and Moses HL: Transforming growth factor β and cell cycle regulation. Cancer Res 55: 1452-1457, 1995.
25. Canatan H, Chang YC, Sugimoto Y, Shidaifat F, Kulp SK, Brueggemeier RW and Lin YC: Keratinocytc growth factor (KGF/FGF-7) has a paracrine role in canine prostate: Molecular cloning of mRNA encoding canine KGF. DNA and Cell Biol 15: 247-254, 1996.
26. Sehy DW, Shao L-E, Yu AL, Tsai W-M and Yu J: Activin-A-induced differentiation in K562 cells is associated with transient hypophosphorylalion of RB protien und the concomitant block of cell cycle at the G1 phase. J Cellular Biochemistry 50: 225-256, 1992.
27. Chomczynski P and Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroformextniction. Anal Biochem 162: 156-159, 1987.
28. Rosenberg LJ, Adlakha RC, Desai DM and Rao PN: Inhibition of DNA polymerase-α by gossypol. Biochim Biophys Acta 866: 258-267, 1986.
29. Adlakha RC, Ashorn CL, Chan D and Zwelling LA: Modulation of 4'-(9-Acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage hy gossypol. Cancer Res 49: 2052-2058, 1989.
30. Zheng J, Shidaifat F, Zhang Y, Sugimoto Y, Canatan H, Kulp SK, Farrar WB. Brueggemeier RW and Lin YC Gossypol stimulate transforming growth factor-β (TGF-β) gene expression in human breast cancer cell line. FASEB J 10: 4374A, 1996.
31. 2+-dependent protein kinase from pig testis. Bioch Biophys Acta 839: 276-280, 1985.
32. Olgiati KL, Toscano DG, Atkins WM and Toscano WA Gossypol inhibition of adenylate cyclase. Arch Biochem Biophys 231: 411-415, 1984.